Syndax


Syndax Pharmaceuticals, Inc (Syndax) is a clinical stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The Company’s product candidate, entinostat, which was granted Breakthrough The...

Industries

Employees

51-200

Links


Org chart

Collapse
Peter Ordentlich
Chief Scientific Officer and Founder
Anjali Ganguli
Chief Business Officer
Kevin McManus
Chief People Officer
Nate Ide
Senior Vice President, Market Access And Global Value
Steven Closter
Chief Commercial Officer (cco)
Roxanne Daugherty-Sim
Director, GMP Quality Commercial
Shane O'Connell
Executive Director - Corporate Counsel
Dennis O'Brien
Vice President, Head Of Drug Safety And Pharmacovigilance
Angela I
Associate Director Of Clinical Operations
Michelle Busa
Executive Director, Clinical Data Management
Norman Nagl
Vice President, Medical Affairs

Board & advisors